Spectral Medical Inc T.EDT

The big 3 - 0

[mercedesman]

Key Tigris Trial Updates:

• Patient mortality data continues to exceed expectations
• 30 patients randomized to-date (out of the 150 total patients to be enrolled in the Tigris trial)
• Of the three patients enrolled over the past month, two were enrolled as a result of the recent FDA approved protocol amendment allowing for the use of sequential organ failure assessment (SOFA) scoring as inclusion criteria into the study
• Investigator meeting scheduled for February 17, 2022, expected to be well attended by existing and new trial sites

[Domino55]

Good summary MM - Only seen by 8-9% of potential North American investors at the absolute most but it would seem there is no immediate solution for that deficiency. Oh Well